Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantumzyme (QTZM) Notes Payables (2024 - 2026)

Quantumzyme (QTZM) has 2 years of Notes Payables data on record, last reported at $268594.0 in Q4 2025.

  • For Q4 2025, Notes Payables changed N/A year-over-year to $268594.0; the TTM value through Oct 2025 reached $268594.0, changed N/A, while the annual FY2025 figure was $249081.0, 48.56% up from the prior year.
  • Notes Payables reached $268594.0 in Q4 2025 per QTZM's latest filing, up from $249081.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $268594.0 in Q4 2025 and bottomed at $167666.0 in Q3 2024.